Scarica l'app Stockscreener
34.90
1.45%
0.50
Dopo l'orario di chiusura:
35.25
0.35
+1.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
HRMY Down 10.8% In Six Months: How Should You Play The Stock? - Barchart
HRMY Down 10.8% in Six Months: How Should You Play the Stock? - Yahoo Finance
HRMY Crosses Above Key Moving Average Level - Nasdaq
Expert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 Analysts - Benzinga
Mizuho lifts Harmony Biosciences stock target to $44 - Investing.com India
Mizuho lifts Harmony Biosciences stock target to $44 By Investing.com - Investing.com South Africa
Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating - Marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $44 at Mizuho - StreetInsider.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Harmony Biosciences at Leerink Conference: Expanding Horizons in Rare Disorders - Investing.com UK
Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Repor - GuruFocus.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc.HRMY - PR Newswire
Proficio Capital Partners LLC Buys New Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Present at Upcoming Global Healthcare Conferences - MyChesCo
Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - MSN
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire
Amalgamated Bank Buys 2,074 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
Can Harmony Biosciences Reveal New Strategic Plans at Upcoming Miami Healthcare Conferences? - StockTitan
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Principal Financial Group Inc. - Defense World
Equities Analysts Set Expectations for HRMY FY2025 Earnings - Defense World
Harmony Biosciences Reports Record 2024 Revenue, Targets Billion-Dollar Milestone in 2025 - MyChesCo
HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money - ACCESS Newswire
Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Rhumbline Advisers Buys 16,537 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Denali Advisors LLC - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
HC Wainwright Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $70.00 - MarketBeat
Harmony Biosciences Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St
Y Intercept Hong Kong Ltd Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
(HRMY) Trading Report - Stock Traders Daily
Harmony Biosciences Holdings Inc to Host Earnings Call - ACCESS Newswire
Harmony Biosciences Earnings Call Highlights Growth and Challenges - TipRanks
Harmony Biosciences (NASDAQ:HRMY) Shares Down 8.2%Here's Why - MarketBeat
Harmony Biosciences Highlights 2025 Catalysts in Sleep/Wake Franchise - Sleep Review
Demystifying Harmony Biosciences Hldgs: Insights From 11 Analyst Reviews - Benzinga
UBS Adjusts Price Target on Harmony Biosciences to $55 From $56, Keeps Buy Rating - Marketscreener.com
Harmony Biosciences stock target cut to $70 at H.C. Wainwright - Investing.com India
Harmony Biosciences stock target cut to $70 at H.C. Wainwright By Investing.com - Investing.com South Africa
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at H.C. Wainwright - StreetInsider.com
Harmony Biosciences (NASDAQ:HRMY) Earns “Buy” Rating from Needham & Company LLC - Defense World
Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance, Highlights 2025 Catalysts in Sleep, Wake and Fragile X Syndrome Development Programs - Marketscreener.com
Cantor Fitzgerald maintains HRMY stock Overweight rating - Investing.com India
Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance
Cantor Fitzgerald Reiterates Overweight Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2024 Earnings Call Transcript - Insider Monkey
Cautious Outlook: Sell Rating for Harmony Biosciences Due to Pipeline Concerns and Generic Competition Risks - TipRanks
Harmony Biosciences Exceeds Q4 Expectations with $0.85 EPS and $201.3 Million Revenue - GuruFocus.com
Harmony Biosciences to Announce Q4 & Full Year 2024 Results on February 25, 2025 - MSN
Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates - MSN
0.22%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):